Handelsbanken Fonder’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Buy
55,700
+25,700
+86% +$493K ﹤0.01% 1006
2026
Q1
$529K Hold
30,000
﹤0.01% 1278
2025
Q4
$592K Buy
30,000
+6,200
+26% +$111K ﹤0.01% 1247
2025
Q3
$415K Hold
23,800
﹤0.01% 1335
2025
Q2
$333K Buy
+23,800
New +$383K ﹤0.01% 1393
2024
Q2
Sell
-14,700
Closed -$73K 1522
2024
Q1
$73K Hold
14,700
﹤0.01% 1556
2023
Q4
$127K Hold
14,700
﹤0.01% 1539
2023
Q3
$102K Hold
14,700
﹤0.01% 1543
2023
Q2
$85K Hold
14,700
﹤0.01% 1561
2023
Q1
$93K Hold
14,700
﹤0.01% 1530
2022
Q4
$173K Hold
14,700
﹤0.01% 1462
2022
Q3
$174K Hold
14,700
﹤0.01% 1460
2022
Q2
$168K Hold
14,700
﹤0.01% 1521
2022
Q1
$165K Hold
14,700
﹤0.01% 1652
2021
Q4
$207K Buy
+14,700
New +$257K ﹤0.01% 1699

Other funds holding ALHC

Handelsbanken Fonder's ALHC Position: Q2 2026 in Review

Handelsbanken Fonder increased its Alignment Healthcare (ALHC) stake by 86% in Q2 2026, buying an estimated $493K and bringing the position to 55,700 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1006.

Handelsbanken Fonder first reported a position in ALHC in Q4 2021 and has held it in 15 quarters since. 65 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Handelsbanken Fonder held 55,700 shares of Alignment Healthcare worth $1.33M as of Q2 2026.
  • Handelsbanken Fonder bought 25,700 Alignment Healthcare shares in Q2 2026, an estimated $493K.
  • Alignment Healthcare made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1006 holding.
  • Handelsbanken Fonder first reported a position in Alignment Healthcare in Q4 2021 and has held it in 15 quarters since.
  • 65 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.